Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of "HIV Units".

NCT06159894 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz as lead sponsor.

NCT NCT06159894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06159894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of "HIV Units".
Lead sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Phase
Not applicable
Overall status
Completed
Start date
December 18, 2023
Completion date
February 18, 2026
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections